Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2834
Source ID: NCT00290940
Associated Drug: Cs-917
Title: Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: CS-917|DRUG: metformin hydrochloride|DRUG: pioglitazone
Outcome Measures: Primary: Mean change from baseline in HbA1C after 12 weeks compared to placebo | Secondary: Onset of efficacy of CS-917|Safety and tolerability of CS-917|Changes in other relevant glycemic and metabolic measures|Proportion of subjects achieving therapeutic response|Proportion of subjects discontinuing or requiring rescue for continued or worsening hyperglycemia
Sponsor/Collaborators: Sponsor: Daiichi Sankyo
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 400
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2006-01
Completion Date: 2007-04
Results First Posted:
Last Update Posted: 2007-09-11
Locations: Birmingham, Alabama, 35205, United States|Northport, Alabama, 35476, United States|Mesa, Arizona, 85201, United States|Phoenix, Arizona, 85014, United States|Tempe, Arizona, 85282, United States|Hot Springs, Arkansas, 71913, United States|Cudahy, California, 90201, United States|Long Beach, California, 90806, United States|Roseville, California, 95661, United States|Sacramento, California, 95841, United States|Spring Valley, California, 91978, United States|Studio City, California, 91604, United States|Vista, California, 92083, United States|Walnut Creek, California, 94598, United States|West Hills, California, 91307, United States|Wilmington, Delaware, 19805, United States|Brooksville, Florida, 34613, United States|Fort Lauderdale, Florida, 33308, United States|Kissimmee, Florida, 34741, United States|Miami, Florida, 33156, United States|Pembroke Pines, Florida, 33028, United States|Sebastian, Florida, United States|St. Petersburg, Florida, 33709, United States|Tallahassee, Florida, 32308, United States|West Palm Beach, Florida, 33401, United States|Rome, Georgia, United States|Warner Robins, Georgia, 31093, United States|Shawnee Mission, Kansas, 66216, United States|Topeka, Kansas, 66614, United States|Topeka, Kansas, United States|Oxon Hill, Maryland, 20745, United States|Cadillac, Michigan, 49601, United States|Detroit, Michigan, 48235, United States|Interlochen, Michigan, 49643, United States|Livonia, Michigan, 48152, United States|Port Gibson, Mississippi, 39150, United States|Rolling Fork, Mississippi, 39159, United States|Excelsior Springs, Missouri, 64024, United States|Henderson, Nevada, 89052, United States|Las Vegas, Nevada, 89103, United States|Elizabeth, New Jersey, 07202, United States|Toms River, New Jersey, 08755, United States|Charlotte, North Carolina, 28262, United States|Lenoir, North Carolina, 28645, United States|Raleigh, North Carolina, 27612, United States|Winston-Salem, North Carolina, 27103, United States|Cincinnati, Ohio, 45219, United States|Delaware, Ohio, 43015, United States|Marion, Ohio, 43302, United States|Oklahoma City, Oklahoma, 73103, United States|Beaver, Pennsylvania, 15009, United States|Bensalem, Pennsylvania, 19020, United States|Pittsburgh, Pennsylvania, 15206, United States|Reading, Pennsylvania, 19696, United States|Anderson, South Carolina, 29621, United States|Charleston, South Carolina, United States|Greer, South Carolina, United States|Nashville, Tennessee, United States|Corpus Christi, Texas, 78404, United States|Houston, Texas, 77024, United States|Lake Jackson, Texas, 77566, United States|North Richland Hills, Texas, United States|San Antonio, Texas, 78229, United States|Burke, Virginia, United States|Olympia, Washington, 98502, United States|Madison, Wisconsin, 53719, United States
URL: https://clinicaltrials.gov/show/NCT00290940

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D336 Pioglitazone small molecule DB01132 Details